Jonathan M. Meyer

Statistics

Publications

Citations

1.9K

H-Index

Active since

1997

Affiliations

University of California San Diego(Current)

VA San Diego Healthcare System

IQVIA (United States)

Duke University

National Institute of Mental Health

Jonathan M. Meyer is an author at University of California San Diego specializing in antipsychotic therapy, antipsychotic pharmacology, and antipsychotic pharmacotherapy.

Publications per year

1997–2014

Publications

Prevalence of the metabolic syndrome in patients with schizophrenia: Baseline results from the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) schizophrenia trial and comparison with national estimates from NHANES III

Joseph P. McEvoy, Jonathan M. Meyer, Donald Goff et al. · Schizophrenia Research · 2005 · 1.1K citations

Medicine, Psychiatry, Adult Psychiatry +10

Change in metabolic syndrome parameters with antipsychotic treatment in the CATIE Schizophrenia Trial: Prospective data from phase 1

Jonathan M. Meyer, Vicki G. Davis, Donald Goff et al. · Schizophrenia Research · 2008 · 287 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +13

Antipsychotic effects on estimated 10-year coronary heart disease risk in the CATIE schizophrenia study

Gail L. Daumit, Donald Goff, Jonathan M. Meyer et al. · Schizophrenia Research · 2008 · 222 citations · Full text

Medicine, Cardiology, Psychiatry +16

Inflammatory Markers in Schizophrenia: Comparing Antipsychotic Effects in Phase 1 of the Clinical Antipsychotic Trials of Intervention Effectiveness Study

Jonathan M. Meyer, Joseph P. McEvoy, Vicki G. Davis et al. · Biological Psychiatry · 2009 · 108 citations · Full text

Medicine, Pharmacotherapy, Psychiatry +16

Impact of antipsychotic treatment on nonfasting triglycerides in the CATIE Schizophrenia Trial phase 1

Jonathan M. Meyer, Vicki G. Davis, Joseph P. McEvoy et al. · Schizophrenia Research · 2008 · 74 citations · Full text

Medicine, Pharmacology, Psychiatry +14

1–5 of 7